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December 20121816 Abstractshemodynamics, which may enhance outcomes and reduce secondary
interventions for recurrent stenosis.
Table. Hemodynamic parameters
Variable 30-day duplex scan Most recent duplex scan
50%
DR
50-75%
DR
75%
DR
50%
DR
50-75%
DR
75%
DR
Angio alone, No.
(%)
152 15 (9) 0 141 21 (13) 5 (3)
Mean PSV (cm/s) 98  46 198  47 . . . 106  38 204  51 422  45
Angio  IVUS,
No. (%)
233 8 (3) 0 232 8 (3) 1 (0.4)
Mean PSV (cm/s) 84  50 182  31 . . . . 82  40 186  28 347
Stress Tests Are Overutilized in the Preoperative Evaluation of Endo-
vascular Aneurysm Repair
Siddharth Patel, Richard Gilmore, Yazan Duwayri, Ravi Rajani, James
Reeves, Luke Brewster, Thomas Dodson, Ravi Veeraswamy. Emory Uni-
versity School of Medicine, Atlanta, Ga
Introduction: The ideal approach for cardiac risk stratification in patients
undergoing elective endovascular aortic aneurysm repair (EVAR) remains un-
resolved. Multiple algorithms are used to evaluate patients, with significant
variability amongst institutions, and cardiac stress testing remains a widely used
modality. Recent American College of Cardiology/American Heart Associa-
tion guidelines suggest clinical risk factors can identify patients at highest risk for
adverse events. We compared the clinical efficacy and cost-savings of risk factor
assessment using the revised cardiac risk index (RCRI) vs cardiac stress testing in
predicting perioperative cardiac complications after EVAR.
Methods: A single-center retrospective study was conducted to identify
patients undergoingEVARbetween 2009 and 2011.Of 248 patients whowere
identified, 42 were excluded due to emergent repair, and 206 patients were
included in the analysis. The preoperative assessment was identified and a cost
analysis was performed based on CMS reimbursement rates for our geographic
area. The RCRI was calculated for each patient and used to stratify them
according to predicted risk for a perioperative cardiac event. The 30-day event
rates for death or symptomatic cardiac events were calculated.
Results: Complete records for preoperative evaluations were available
for 197 of the 206 patients. Of those, 168 (85%) underwent cardiac stress
testing, of which 26 patients (13%) were positive, resulting in further testing.
Twenty patients with a positive stress test underwent cardiac catheterization,
three underwent percutaneous coronary intervention (PCI), and one under-
went coronary artery bypass grafting. There were no perioperative deaths.
Six patients (2.9%) had clinical symptoms prompting measurement of serum
troponin levels, which were elevated. In patients with a negative stress test,
five myocardial infarctions (MIs) occurred (3%) vs one MI in patients with a
positive stress test (3.8%; P  .86). When stratified by the RCRI, patients
with fewer than three risk factors had anMI rate of 2.5% vs 16.7% in patients
with three or more factors (P .04). Including the resultant procedures, the
per-patient cost for routine preoperative stress testing was $3500.
Conclusions: Routine preoperative cardiac stress testing for patients
undergoing elective endovascular aneurysm repair is unwarranted. It results
in additional invasive testing and therapy with a concomitant cost increase.
The RCRI is a reliable tool for risk stratification and guiding preoperative
workup in patients scheduled for elective EVAR. The RCRI should replace
qualitative physician determination of fitness for EVAR. This represents a
potential area for improved resource utilization strategies.
Table. Stress test and perioperative MI by risk score
RCRI risk score
Stress test, No. (%) MI, No. (%)
Yes No. Yes No.
3 163 (85) 28 (15) 5 (2.5) 195 (97.5)
3 5 (83) 1 (17) 1 (17) 5 (83)
Percutaneous Endovascular Aortic Aneurysm Repair (PEVAR): Re-
sults From the First Prospective, Multicenter Randomized Trial
Peter R. Nelson. University of Florida College of Medicine, Gainesville, Fla
Introduction: The first randomized controlled trial was designed and
conducted to assess the safety and effectiveness of totally percutaneous
endovascular aortic aneurysm repair (PEVAR) using a 21F endovascular
stent graft system and an 8F or 10F suture-mediated closure system. A
noninferiority trial design was chosen to compare percutaneous access to
standard open femoral exposure.Methods: Between 2010 and 2012, 20 United States institutions
participated in a prospective, U.S. Food and Drug Administration-approved
a
sandomized trial to evaluate the safety and effectiveness of percutaneous
emoral artery access and closure using a “preclose” technique in conjunc-
ion with EVAR. A total of 192 patients were enrolled, 41 in a nonrandom-
zed roll-in phase, and then 151 in the randomized phase where patients
ere allocated 2:1 to percutaneous closure (group C, n  101) or open
emoral exposure (group S, n  50). PEVAR procedures were performed
sing the 8F Perclose ProGlide (group C1, n  50) or the 10F Prostar XL
group C2, n  51) closure device. All EVAR procedures were performed
ith the 21F profile IntuiTrak System. Patients were screened using com-
uted tomography with 3-dimensional reconstruction and independent
hysician review for anatomic suitability and adequate femoral artery anat-
my for percutaneous access (eg, absence of anterior wall or circumferential
alcification, aneurysm, or extensive scarring). Primary treatment success
as defined as procedural technical success and absence of adverse systemic
nd access-related vascular events at 30 days. Secondary clinical utility and
rocedural outcomes, ankle-brachial index, blood laboratory analyses, and
uality of life were also evaluated with continuing follow-up to 6 months.
Results: Baseline characteristics were similar among all groups. EVAR
echnical success was 100%, 100%, and 98% in groups C1, C2, and S,
espectively. Primary treatment success at 1 month was 88% (C1), 78% (C2),
nd 78% (S) with a one-sided Blackwelder’s test of noninferiority yielding
 .0036 for C1 vs S and P  .1021 for C2 vs S. Secondary outcomes
rocedurally to within 1 month are shown in the Table. PEVAR (group C)
ompared favorably with respect to time to hemostasis, anesthesia time, total
rocedure time, analgesic use, ipsilateral groin pain, blood transfusion require-
ent, and quality of life metrics. Final 6-month follow-up is ongoing.
Conclusions: Among trained operators and patients with suitable femo-
al artery anatomy, a totally percutaneous approach to EVAR is safe, with
inimal access-related complications. The ProGlide suture-mediated device
pecifically performed noninferiorly to standard open femoral exposure. Train-
ng, experience, and careful application of the “preclose” technique is of para-
ount importance in ensuring successful, sustainable outcomes.
able.
utcome measure Group C1 Group C2 Group S
nesthesia time, minutes 181  65 152  54a 203  93
ime to hemostasis, minutes 9.8  17a 13  19a 23  23
otal procedure Time, minutes 101  43a 95  35a 136  71
stimated blood loss, mL 213  205 193  198 280  290
lood transfusion, % patients 4.0% 16% 14%
ime to ambulation, hours 17  7.2 16  9.1 19  16
ime to normal diet, hours 14  9.4 10  8.4 15  22
psilateral groin pain
pre-dischargeb
2.1  2.2 1.4  2.0a 2.6  2.4
nalgesics for groin pain
pre-discharge, % patients
18% 12%a 30%
ime to hospital discharge, days 1.3  0.7 1.4  0.9 1.8  2.4
psilateral groin pain at 1
monthb
0.4  0.9 0.1  0.5a 0.6  1.5
F-36 health-related quality of
life change at 1 month
9.4  26 8.3  29 1.6  24
psilateral ankle-brachial index
at 1 month
1.06  0.16 1.05  0.15 1.06  0.13
esults shown as mean  SD unless otherwise specified.
P.05 vs group S result.
Scale of 0 (no pain) to 10 (worst pain imaginable).
equential Catheterization Amid Progressive Endograft Deployment
or Fenestrated and Branched Endovascular Aortic Aneurysm Repair
regory A. Stanley, Carlos H. Timaran, M. Shadman Baig, J. Gregory
odrall, David E. Timaran, L. F. Gomez, R. James Valentine. University of
exas Southwestern, Dallas, Tex
Introduction: Fenestrated and branched endovascular aneurysm repair
FEVAR) is an alternative to open repair of complex aortic aneurysms in
igh-risk patients. Unfortunately, patients with unfavorable anatomy are fre-
uently denied FEVAR because of the risk of technical failure with loss of
isceral arteries. The purpose of this study was to assess technical success of
EVAR using a sequential catheterization amid progressive endograft deploy-
ent (SCAPED) technique, particularly in patients with unfavorable anatomy.
Methods: During a 12-month period, 39 high-risk patients (31 men
nd 8 women) underwent FEVAR using customized, physician-modified
enith endografts that were fenestrated or branched using the SCAPED
echnique. The visceral vessels were sequentially catheterized through the
enestrations via left brachial artery access in a cranial-to-caudal direction as
he endograft was progressively deployed. Each fenestration was deployed,
ligned, and catheterized separately while the distal endograft was con-
trained within the delivery sheath. Technical success was defined as com-
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patent fenestrated/branched visceral arteries.
Results: Median age was 74 years (interquartile range [IQR], 64-81
years). All patients were considered unfit for open repair and had a median
Society for Vascular Surgery comorbidity score of 15 (IQR, 12-18). Median
aneurysm size was 5.9 cm (IQR, 5.5-6.4 cm). Most aortic aneurysms were
paravisceral (40%); 23% were thoracoabdominal aortic aneurysms and 37%
were juxtarenal abdominal aortic aneurysms. Endografts were customized to
include 102 fenestrations/branches (63 renal, 28 superior mesenteric, and
11 celiac arteries). Fourteen patients (36%) had complex aortic aneurysms
with unfavorable anatomy because of severe suprarenal neck angulation
(45°) or tortuosity in five (13%), reverse taper configuration of the
proximal neck in four (10%), and circumferential thrombus/atheroma
above the renal arteries in five (13%). Severe preprocedural renal and visceral
artery stenosis was present in five and four patients, respectively. Technical
success for stenting of the fenestrated/branched arteries was 98% (100 of
102). In two patients with unfavorable anatomy, one renal artery was lost
and the corresponding fenestration had to be sealed with a cuff or a vascular
plug. No visceral arteries were lost. Median procedure time was 265minutes
(IQR, 168-348 minutes), and median fluoroscopy time was 73 minutes
(IQR, 51-86 minutes). Median contrast load was 103 mL (IQR, 91-130
mL) and estimated blood loss 250 mL (IQR, 125-550 mL). Median
procedure (272 vs 255) and fluoroscopy times (76 vs 72) were not signifi-
cantly different between patients with and without unfavorable anatomy
(P  .05). No 30-day mortality occurred. Median hospital stay was 6 days
(IQR, 4-9 days). Blue toe syndrome because of embolization (3 patients),
access vessel injury (2 patients), worsening renal insufficiency (2 patients),
renal artery dissection (2 patients), and myocardial infarction (1 patient)
were themore frequent procedure-related complications. No periprocedural
paraplegia or strokes occurred.
Conclusions: FEVAR using the SCAPED technique is safe and effec-
tive in the treatment of complex aortic aneurysms, even in patients with
unfavorable anatomy.
A Case-Matched Validation Study of Anatomic Severity Grade Score in
Predicting Reinterventions After Endovascular Aortic Aneurysm Repair
Patricia G. Johnson, Candice R. Chipman, Jung H. Kim, Samuel N. Steer-
man, Jonathan A. Higgins, David J. Dexter, Sadaf S. Ahanchi, Jean M.
Panneton. Eastern Virginia Medical School, Norfolk, Va
Introduction: In 2002, the Society for Vascular Surgery (SVS) created
the anatomic severity grading (ASG) score to classify abdominal aortic
aneurysms (AAA). We have previously correlated high ASG score with
increased technical difficulty during endovascular aneurysm repair (EVAR).
The objective of our study was to identify the predictive capability and cutoff
value of preoperative ASG score for reintervention after EVAR.
Methods:We completed a retrospective review of AAA patients treated
with elective EVAR from 2007 to 2011. Patients who had reinterventions as
well as preoperative M2S 3-dimensional reconstructions were identified and
then compared with a case-matched control group of patients without
reintervention. ASG component scores (neck, aortic, and iliac) and total
ASG scores were calculated using M2S software (M2S Inc, NH). Student t
test was used to calculate P values where P .05 is significant. An area under
the receiver operating curve (AUROC) was created to identify the critical
ASG score for predicting reintervention.
Results: A total of 623 AAA patients were treated with EVAR within
the 5-year study period. Of those, 79 (13%) had reinterventions. Of the 79
reintervention patients, 45 had preoperativeM2S 3-dimensional reconstruc-
tions available for ASG score calculation. The reintervention group (mean
age 74 8 years, 80% men) had a mean ASG score of 18 5 (range, 8-30)
and was compared with the case-matched control group of 45 EVAR
patients (mean age 74  7 years, 80% men) who had a mean ASG score of
13  4 (range, 4-21; P  .0001). Demographics and risk factors were not
significantly different between the two groups. The mean AAA diameter for
all patients was 52 14 mm and was not significantly different between the
reintervention and non-reintervention groups. After AUROC analysis, an
ASG score of 17 was highly predictive for reintervention (area, 0.8; sensitiv-
ity, 60%; specificity, 78%; positive predictive value, 73%; negative predictive
value, 66%). An ASG score 17 yielded a 34% reintervention rate, whereas
an ASG score17 yielded a 73% reintervention rate (P .0002). The lowest
ASG score that yielded a 100% reintervention rate was 22. Most reinterven-
tions fell into three categories: proximal extension cuff (17 [38%]), distal
extension cuff (8 [18%]), and type II endoleak embolization (12 [27%]).
Those that received proximal extensions had significantly higher mean total
ASG score vs the case-matched controls (19 vs 15, P  .0005) as well as
significantly higher individual component scores of mean neck score (3 vs 2,
P .047) andmean aorta score (7 vs 5, P .004). Those that received distal
extensions had significantly higher mean iliac score vs the case-matched
controls (mean of 9 vs 7, P .013), and those that required an embolization
had a significantly higher mean aorta branch score compared with the
case-matched controls (mean of 2 vs 1; P  .017).Conclusions: Preoperative total ASG score strongly predicts reinter-
vention after EVAR. Use of a cutoff ASG value predictive of prohibitive
p
7eintervention rates can help guide the decision between endovascular vs
pen AAA repair.
he Risk of Elevated Radiation Dose in Complex Endovascular Proce-
ures: Surgeon Education Improves Patient Safety
elissa L. Kirkwood, GaryM. Arbique, Jeffrey B. Guild, Carlos Timaran, R.
ames Valentine, Jayer Chung, Jon A. Anderson. University of Texas
outhwestern Medical Center, Dallas, Tex
Introduction: Complex endovascular procedures (CEP), such as fe-
estrated endovascular aneurysm repair (FEVAR), are associated with
igher radiation doses compared with other fluoroscopically guided inter-
entions (FGI). The purpose of this study was to determine whether surgeon
ducation on radiation dose control can lead to lower reference air kerma
RAK) and peak skin dose (PSD) levels in high-dose procedures.
Methods: Radiation dose and operating factors were recorded for FGI
erformed in a hybrid room over a 17-month period. Cases exceeding 6 Gy
AK were investigated according to institutional policy. Information ob-
ained from these investigations led to surgeon education consisting of
ersonalized instruction and a 1-hour lecture focused on reducing patient
ose. Points addressed included increasing table height, using collimation
nd angulation, decreasing magnification modes, and maintaining minimal
atient-to-detector distance. Procedural RAK doses and operating factors
ere compared 8 months before and 8 months after the educational inter-
ention using analysis of variance with Tukey pairwise comparisons and t
ests. Peak skin dose (PSD) distributions were calculated using custom
oftware using input data from fluoroscopic machine logs.
Results: Of 447 procedures performed, 300 FGI had sufficient data to
e included in the analysis (54% lower extremity, 11% TEVAR, 10% cerebral,
% FEVAR, 7% EVAR, 5% visceral, and 5% embolization). Twenty cases
ere further investigated for exceeding 6 Gy RAK (14 FEVAR, 3 emboli-
ation, 1 EVAR, 1 TEVAR, 1 visceral). FEVAR represented only 8% of cases
erformed; however, FEVAR comprised 70% of the cases investigated for
eaching 6 Gy RAK and had five times the average RAK dose compared with
ll other FGI performed (P  .0001). Degree of fenestration ranged from
ne to four vessels, and there was no difference in RAK dose based on
umber of vessels fenestrated. The effect of surgeon education on radiation
ose was seen in all cases, regardless of complexity. Compared with the
re-education data set, the posteducation table height was 10 cm higher on
verage (P  .0001) per case, resulting in an estimated 15% reduction in
SD. Additionally, the use of collimation also increased from 25% to 40%
P  .001) for all cases, further reducing PSD. There was no observable
hange in other operating factors, including the use of magnification or
ngulation. The number of cases that exceeded 6 Gy RAK did not change
fter education; however, the proportion of non-FEVAR cases that exceeded
Gy decreased from 40% to 20%.
Conclusions: These data show that radiation doses associated with
EVAR are significantly greater than doses associated with all other FGI.
urgeon education focused on good fluoroscopic operating factors can
ower patient PSD; therefore, vascular surgeons must not only be aware of
he potential for high radiation dose in CEP but also be vigilant in efforts to
educe exposure to themselves and the patient.
ndovascular Repair of a Ruptured Subclavian Artery Aneurysm in a
atient With Ehlers-Danlos Syndrome Using a Sandwich Technique
apan S. Desai, Maria Codreanu, Kristofer Charlton-Ouw, Hazim Safi, Ali
zizzadeh. University of Texas Houston Medical School and Memorial
ermann Hospital, Houston, Tex
Introduction: A defect in collagen synthesis leads to extreme vascular
ragility in patients with type IV Ehlers-Danlos syndrome. Most patients
evelop significant vascular complications by the age of 40 years. Open
urgical repair remains a formidable challenge that is fraught with compli-
ations. We present the case of a patient with a ruptured subclavian artery
neurysm and associated arteriovenous fistula who underwent successful
ndovascular repair. Lack of a proximal seal zone in the subclavian artery
neurysm necessitated simultaneous stent graft repair of the innominate
rtery using a sandwich technique.
Methods: A 17-year-old man with known type IV Ehlers-Danlos
yndrome developed right neck and shoulder swelling after a sports-related
ervical hyperextension injury. He was intubated on arrival for airway
ompromise. A computed tomography angiography study demonstrated a
7-  13-cm ruptured subclavian artery aneurysm with an associated inter-
al jugular vein arteriovenous fistula. He was emergently taken to the hybrid
perating suite for repair. An aortogram was obtained via an open right
emoral exposure (Fig 1). The right brachial artery was exposed (8F). A wire
as passed from the right femoral approach into the right brachial artery and
etrieved through the sheath. A 7-mm  15-cm stent graft (Viabahn, WL
ore & Associates, Flagstaff, Ariz) was advanced from the right brachial
pproach into the innominate artery. Simultaneously, using a separate wire
laced into the right carotid artery via the right femoral approach (7F), a
-mm  10-cm stent graft (Viabahn) was advanced into the innominate
